Clinical Trials Logo

Clinical Trial Summary

This is a Phase 2b, randomized, double blind, placebo and active controlled study with an Ascending Dose Stage and an optional Dose Expansion Stage in subjects undergoing open inguinal herniorrhaphy with mesh.


Clinical Trial Description

A Randomized, Double-Blind, Placebo- and Active-Controlled, Dose Escalation and Optional Dose Expansion Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CPL-01 in the Management of Postoperative Pain After Open Inguinal Herniorrhaphy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05080959
Study type Interventional
Source Cali Pharmaceuticals LLC
Contact
Status Completed
Phase Phase 2
Start date July 28, 2021
Completion date June 10, 2022

See also
  Status Clinical Trial Phase
Terminated NCT00616577 - Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine N/A
Terminated NCT03534505 - Post-Operative Analgesic Effects of Local Wound Infiltration With Ketorolac After Inguinal Herniorrhaphy N/A
Recruiting NCT06352606 - Spinal and General Anesthesia in Neonates Undergoing Herniorrhaphy N/A